Literature DB >> 23614752

Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin.

Gary P Sidgwick, Syed A Iqbal, Ardeshir Bayat.   

Abstract

Keloid disease (KD) is a fibroproliferative disorder characterised partly by an altered extracellular matrix (ECM) profile. In fetal scarring, hyaluronic acid (HA) expression is increased, but is reduced in KD tissue compared with normal skin (NS). The expression of Hyaluronan Synthase (HAS) and hyaluronidase (HYAL) in KD and NS tissue were investigated for the first time using a range of techniques. Hyaluronan synthase and HYAL mRNA expression were significantly increased in NS tissue compared with KD tissue (P < 0.05). Immunohistological analysis of tissue indicated an accumulation of HAS and HYAL protein expression in KD compared with NS due to the thicker epidermis. No differences were observed in mRNA or protein expression in KD and NS fibroblasts. Reduced expression of HAS and HYAL may alter HA synthesis, degradation and accumulation in KD. Better understanding of the role of HA in KD may lead to novel therapeutic approaches to address the resulting ECM imbalance.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23614752     DOI: 10.1111/exd.12147

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

Review 1.  Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound.

Authors:  Lauren E Tracy; Raquel A Minasian; E J Caterson
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-03-01       Impact factor: 4.730

2.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

3.  Hyaluronidase decreases neutrophils infiltration to the inflammatory site.

Authors:  Marcio Fronza; Cornélia Muhr; Denise Sayuri Calheiros da Silveira; Carlos Artério Sorgi; Stephen Fernandes de Paula Rodrigues; Sandra Helena Poliselli Farsky; Francisco Wanderley Garcia Paula-Silva; Irmgard Merfort; Lúcia Helena Faccioli
Journal:  Inflamm Res       Date:  2016-03-04       Impact factor: 4.575

4.  Deficiency of hyaluronan synthase 1 (Has1) results in chronic joint inflammation and widespread intra-articular fibrosis in a murine model of knee joint cartilage damage.

Authors:  D D Chan; W F Xiao; J Li; C A de la Motte; J D Sandy; A Plaas
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

5.  MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.

Authors:  Shengzhi Mu; Bei Kang; Weihui Zeng; Yaowen Sun; Fan Yang
Journal:  Mol Cell Biochem       Date:  2016-04-13       Impact factor: 3.396

6.  MicroRNA-26a inhibits hyperplastic scar formation by targeting Smad2.

Authors:  Jun Qi; Yifei Liu; Kesu Hu; Yi Zhang; Yangyang Wu; Xia Zhang
Journal:  Exp Ther Med       Date:  2018-03-21       Impact factor: 2.447

Review 7.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

8.  tRNA‑derived small RNAs: A novel class of small RNAs in human hypertrophic scar fibroblasts.

Authors:  Yaping Zhang; Qin Deng; Longxiang Tu; Dan Lv; Dewu Liu
Journal:  Int J Mol Med       Date:  2019-11-25       Impact factor: 4.101

9.  Skin-specific knockdown of hyaluronan in mice by an optimized topical 4-methylumbelliferone formulation.

Authors:  Emily H Steen; Walker D Short; Hui Li; Umang M Parikh; Alexander Blum; Natalie Templeman; Nadine Nagy; Paul L Bollyky; Sundeep G Keswani; Swathi Balaji
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.